scholarly journals A Prospective, Randomized, Masked, Placebo‐Controlled Multisite Clinical Study of Grapiprant, an EP 4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis

2016 ◽  
Vol 30 (3) ◽  
pp. 756-763 ◽  
Author(s):  
L. Rausch‐Derra ◽  
M. Huebner ◽  
J. Wofford ◽  
L. Rhodes
Keyword(s):  
Clinical Study ◽  
Receptor Antagonist ◽  
Prostaglandin Receptor

scholarly journals Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin

Stroke ◽  
2014 ◽  
Vol 45 (8) ◽  
pp. 2348-2353 ◽  
Author(s):  
Michiel L. Bots ◽  
Ian Ford ◽  
Suzanne M. Lloyd ◽  
Stephane Laurent ◽  
Pierre J. Touboul ◽  
...  
Keyword(s):  
Cerebrovascular Disease ◽  
Receptor Antagonist ◽  
Carotid Atherosclerosis ◽  
Atherosclerosis Progression ◽  
Prostaglandin Receptor

scholarly journals Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats

Critical Care ◽  
2019 ◽  
Vol 23 (1) ◽  
Author(s):  
David Lagier ◽  
David Tonon ◽  
Philippe Garrigue ◽  
Benjamin Guillet ◽  
Laura Giacomino ◽  
...  
Keyword(s):  
Subarachnoid Haemorrhage ◽  
Receptor Antagonist ◽  
Prostaglandin Receptor

scholarly journals Grapiprant: an EP 4 prostaglandin receptor antagonist and novel therapy for pain and inflammation

2015 ◽  
Vol 2 (1) ◽  
pp. 3-9 ◽  
Author(s):  
Kristin Kirkby Shaw ◽  
Lesley C. Rausch‐Derra ◽  
Linda Rhodes
Keyword(s):  
Receptor Antagonist ◽  
Novel Therapy ◽  
Prostaglandin Receptor
Sign in / Sign up

Export Citation Format

Share Document